Quantum Critical Superfluid Flows and Anisotropic Domain Walls

We construct charged anisotropic AdS domain walls as solutions of a consistent truncation of type IIB string theory. These are a one-parameter family of solutions that flow to an AdS fixed point in the IR, exhibiting emergent conformal invariance and quantum criticality. They represent the zero-temperature limit of the holographic superfluids at finite superfluid velocity constructed in arXiv:1010.5777. We show that these domain walls exist only for velocities less than a critical value, agreeing in detail with a conjecture made there. We also comment about the IR limits of flows with velocities higher than this critical value, and point out an intriguing similarity between the phase diagrams of holographic superfluid flows and those of ordinary superconductors with imbalanced chemical potential.Comment: 11 pages, 3 figures. V2: Very minor corrections. JHEP versio

Type IIB Holographic Superfluid Flows

We construct fully backreacted holographic superfluid flow solutions in a five-dimensional theory that arises as a consistent truncation of low energy type IIB string theory. We construct a black hole with scalar and vector hair in this theory, and study the phase diagram. As expected, the superfluid phase ceases to exist for high enough superfluid velocity, but we show that the phase transition between normal and superfluid phases is always second order. We also analyze the zero temperature limit of these solutions. Interestingly, we find evidence that the emergent IR conformal symmetry of the zero-temperature domain wall is broken at high enough velocity.Comment: v3: Published version. Figures 5 and 6 corrected. 24 pages, 7 figure

Towards an Explicit Model of D-brane Inflation

We present a detailed analysis of an explicit model of warped D-brane inflation, incorporating the effects of moduli stabilization. We consider the potential for D3-brane motion in a warped conifold background that includes fluxes and holomorphically-embedded D7-branes involved in moduli stabilization. Although the D7-branes significantly modify the inflaton potential, they do not correct the quadratic term in the potential, and hence do not cause a uniform change in the slow-roll parameter eta. Nevertheless, we present a simple example based on the Kuperstein embedding of D7-branes, z_1=constant, in which the potential can be fine-tuned to be sufficiently flat for inflation. To derive this result, it is essential to incorporate the fact that the compactification volume changes slightly as the D3-brane moves. We stress that the compactification geometry dictates certain relationships among the parameters in the inflaton Lagrangian, and these microscopic constraints impose severe restrictions on the space of possible models. We note that the shape of the final inflaton potential differs from projections given in earlier studies: in configurations where inflation occurs, it does so near an inflection point. Finally, we comment on the difficulty of making precise cosmological predictions in this scenario. This is the companion paper to arXiv:0705.3837.Comment: 68 pages, 6 figures; v2: fixed typos, added refs and clarifications; v3: expanded discussion of inflection point inflatio

Does publication bias inflate the apparent efficacy of psychological treatment for major depressive disorder? A systematic review and meta-analysis of US national institutes of health-funded trials

Background The efficacy of antidepressant medication has been shown empirically to be overestimated due to publication bias, but this has only been inferred statistically with regard to psychological treatment for depression. We assessed directly the extent of study publication bias in trials examining the efficacy of psychological treatment for depression. Methods and Findings We identified US National Institutes of Health grants awarded to fund randomized clinical trials comparing psychological treatment to control conditions or other treatments in patients diagnosed with major depressive disorder for the period 1972–2008, and we determined whether those grants led to publications. For studies that were not published, data were requested from investigators and included in the meta-analyses. Thirteen (23.6%) of the 55 funded grants that began trials did not result in publications, and two others never started. Among comparisons to control conditions, adding unpublished studies (Hedges’ g = 0.20; CI95% -0.11~0.51; k = 6) to published studies (g = 0.52; 0.37~0.68; k = 20) reduced the psychotherapy effect size point estimate (g = 0.39; 0.08~0.70) by 25%. Moreover, these findings may overestimate the "true" effect of psychological treatment for depression as outcome reporting bias could not be examined quantitatively. Conclusion The efficacy of psychological interventions for depression has been overestimated in the published literature, just as it has been for pharmacotherapy. Both are efficacious but not to the extent that the published literature would suggest. Funding agencies and journals should archive both original protocols and raw data from treatment trials to allow the detection and correction of outcome reporting bias. Clinicians, guidelines developers, and decision makers should be aware that the published literature overestimates the effects of the predominant treatments for depression

On Holographic Superconductors with DC Current

We study direct currents in a simple holographic realization of a superconducting film. We investigate how the presence of a DC current affects the superconducting phase transition, which becomes first order for any non-vanishing value of the current, as well as several other properties of the superconductor such as the AC conductivity. Near the critical temperature we find a quantitative agreement with several properties of Ginzburg-Landau superconducting films, for example the squared ratio of the maximal and minimal condensate is equal to two thirds. We also comment on the extension of our construction to holographic Josephson junctions

A community-integrated home based depression intervention for older African Americans: descripton of the Beat the Blues randomized trial and intervention costs

ABSTRACT: BACKGROUND: Primary care is the principle setting for depression treatment; yet many older African Americans in the United States fail to report depressive symptoms or receive the recommended standard of care. Older African Americans are at high risk for depression due to elevated rates of chronic illness, disability and socioeconomic distress. There is an urgent need to develop and test new depression treatments that resonate with minority populations that are hard-to-reach and underserved and to evaluate their cost and cost-effectiveness. METHODS/DESIGN: Beat the Blues (BTB) is a single-blind parallel randomized trial to assess efficacy of a non-pharmacological intervention to reduce depressive symptoms and improve quality of life in 208 African Americans 55+ years old. It involves a collaboration with a senior center whose care management staff screen for depressive symptoms (telephone or in-person) using the Patient Health Questionnaire (PHQ-9). Individuals screened positive (PHQ-9 ≥ 5) on two separate occasions over 2 weeks are referred to local mental health resources and BTB. Interested and eligible participants who consent receive a baseline home interview and then are randomly assigned to receive BTB immediately or 4 months later (wait-list control). All participants are interviewed at 4 (main study endpoint) and 8 months at home by assessors masked to study assignment. Licensed senior center social workers trained in BTB meet with participants at home for up to 10 sessions over 4 months to assess care needs, make referrals/linkages, provide depression education, instruct in stress reduction techniques, and use behavioral activation to identify goals and steps to achieve them. Key outcomes include reduced depressive symptoms (primary), reduced anxiety and functional disability, improved quality of life, and enhanced depression knowledge and behavioral activation (secondary). Fidelity is enhanced through procedure manuals and staff training and monitored by face-to-face supervision and review of taped sessions. Cost and cost effectiveness is being evaluated. DISCUSSION: BTB is designed to bridge gaps in mental health service access and treatments for older African Americans. Treatment components are tailored to specific care needs, depression knowledge, preference for stress reduction techniques, and personal activity goals. Total costs are $584.64/4 months; or$146.16 per participant/per month. TRIAL REGISTRATION: ClinicalTrials.gov #NCT00511680

Older women, breast cancer, and social support

One in ten women over the age of 65 will develop breast cancer. Despite this high incidence of breast cancer among older women, social support for them is often inadequate. This paper describes a qualitative study of the impact of a breast cancer diagnosis on older women from racially/ethnically diverse populations and their subsequent need for social support. Forty-seven older African American, Asian American, Caucasian and Latina women between the ages of 65 to 83 participated in a larger study examining the impact of breast cancer on women from racially/ethnically diverse populations and the meaning and nature of social support. The women completed an in-depth qualitative interview on the psychosocial impact of breast cancer and the meaning and nature of social support. The results indicate that there are variations in reactions to a breast cancer diagnosis among older women, and that these reactions impact their experiences with seeking social support at diagnosis and during treatment. Respondents were concerned about their aging bodies, potential dependency on others, and loss of autonomy. At the same time, the severity of cancer treatment and existing co-morbidities often meant they needed to learn to receive support, and to reach out if they had no support. The implications of these findings underscore the older cancer patient’s need to strengthen her supportive networks at the time of diagnosis, during treatment, and post-treatment